U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 193

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr11:120976615
GRCh38:
Chr11:121105906
TBCEL-TECTA, TECTAS366C, S47CAutosomal dominant nonsyndromic hearing loss 12Uncertain significance
(May 4, 2022)
criteria provided, single submitter
2.
GRCh37:
Chr11:121037418
GRCh38:
Chr11:121166709
TBCEL-TECTA, TECTAG1839S, G2153SAutosomal dominant nonsyndromic hearing loss 12, not providedUncertain significance
(May 8, 2023)
criteria provided, multiple submitters, no conflicts
3.
GRCh37:
Chr11:120996123
GRCh38:
Chr11:121125414
TECTA, TBCEL-TECTAF439S, F758SAutosomal dominant nonsyndromic hearing loss 12Uncertain significance
(Sep 19, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr11:121008344
GRCh38:
Chr11:121137635
TBCEL-TECTA, TECTAW1052C, W1371CAutosomal dominant nonsyndromic hearing loss 12Uncertain significance
(Mar 1, 2022)
no assertion criteria provided
5.
GRCh37:
Chr11:120989337-120989338
GRCh38:
Chr11:121118628-121118629
TBCEL-TECTA, TECTAS373fs, S692fsAutosomal dominant nonsyndromic hearing loss 12Pathogenic
(Nov 12, 2021)
criteria provided, single submitter
6.
GRCh37:
Chr11:120983787
GRCh38:
Chr11:121113078
TBCEL-TECTA, TECTAT165S, T484SAutosomal dominant nonsyndromic hearing loss 12Uncertain significance
(Sep 1, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr11:120996198
GRCh38:
Chr11:121125489
TBCEL-TECTA, TECTAY783C, Y464CAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21, not provided
Uncertain significance
(Jun 2, 2023)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr11:120998698
GRCh38:
Chr11:121127989
TBCEL-TECTA, TECTAC671Y, C990YAutosomal dominant nonsyndromic hearing loss 12Uncertain significance
(Jan 3, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr11:120976577
GRCh38:
Chr11:121105868
TBCEL-TECTA, TECTAN34fs, N353fsnot provided, Autosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21
Pathogenic/Likely pathogenic
(Mar 1, 2023)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr11:120996497
GRCh38:
Chr11:121125788
TBCEL-TECTA, TECTAL564F, L883FAutosomal dominant nonsyndromic hearing loss 12Uncertain significance
(Oct 25, 2021)
criteria provided, single submitter
11.
GRCh37:
Chr11:121023664
GRCh38:
Chr11:121152955
TECTA, TBCEL-TECTAL1394M, L1713Mnot providedUncertain significance
(Nov 8, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr11:121037529
GRCh38:
Chr11:121166820
TBCEL-TECTA, TECTAAutosomal dominant nonsyndromic hearing loss 12, not provided, Autosomal recessive nonsyndromic hearing loss 21
Benign
(Sep 10, 2021)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr11:121036092-121036095
GRCh38:
Chr11:121165383-121165386
TBCEL-TECTA, TECTAAutosomal dominant nonsyndromic hearing loss 12, Bilateral sensorineural hearing impairment, not provided
Pathogenic
(Nov 21, 2022)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr11:121033105
GRCh38:
Chr11:121162396
TBCEL-TECTA, TECTAAutosomal recessive nonsyndromic hearing loss 21, not provided, Autosomal dominant nonsyndromic hearing loss 12
Benign
(Sep 10, 2021)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr11:120984398
GRCh38:
Chr11:121113689
TBCEL-TECTA, TECTAI573T, I254TAutosomal dominant nonsyndromic hearing loss 12Uncertain significance
(Sep 12, 2018)
criteria provided, single submitter
16.
GRCh37:
Chr11:121000827
GRCh38:
Chr11:121130118
LOC126861365, TBCEL-TECTA, TECTAE950K, E1269KAutosomal dominant nonsyndromic hearing loss 12Uncertain significance
(Jun 25, 2018)
criteria provided, single submitter
17.
GRCh37:
Chr11:120996279
GRCh38:
Chr11:121125570
TBCEL-TECTA, TECTAR491L, R810LAutosomal dominant nonsyndromic hearing loss 12Uncertain significance
(Apr 10, 2018)
criteria provided, single submitter
18.
GRCh37:
Chr11:121028738
GRCh38:
Chr11:121158029
TBCEL-TECTA, TECTAF1498L, F1817LAutosomal dominant nonsyndromic hearing loss 12, not providedUncertain significance
(Jul 19, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr11:121037413
GRCh38:
Chr11:121166704
TBCEL-TECTA, TECTAC1837Y, C2151YAutosomal dominant nonsyndromic hearing loss 12Likely pathogenic
(Mar 26, 2020)
criteria provided, single submitter
20.
GRCh37:
Chr11:121031086
GRCh38:
Chr11:121160377
TBCEL-TECTA, TECTAS1963R, S1644RAutosomal dominant nonsyndromic hearing loss 12Uncertain significance
(Mar 24, 2019)
criteria provided, single submitter
21.
GRCh37:
Chr11:121058602
GRCh38:
Chr11:121187893
TECTA, TBCEL-TECTAR2021C, R2335Cnot provided, Autosomal dominant nonsyndromic hearing loss 12Conflicting interpretations of pathogenicity
(Sep 27, 2022)
criteria provided, conflicting interpretations
22.
GRCh37:
Chr11:121000623
GRCh38:
Chr11:121129914
LOC126861365, TBCEL-TECTA, TECTAE882K, E1201Knot provided, Autosomal dominant nonsyndromic hearing loss 12Uncertain significance
(Aug 24, 2022)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr11:121008314
GRCh38:
Chr11:121137605
TBCEL-TECTA, TECTAnot provided, Autosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21
Conflicting interpretations of pathogenicity
(Apr 23, 2022)
criteria provided, conflicting interpretations
24.
GRCh37:
Chr11:120996458
GRCh38:
Chr11:121125749
TBCEL-TECTA, TECTAV551Mnot provided, Autosomal recessive nonsyndromic hearing loss 21, Autosomal dominant nonsyndromic hearing loss 12
Conflicting interpretations of pathogenicity
(Apr 11, 2023)
criteria provided, conflicting interpretations
25.
GRCh37:
Chr11:120980141
GRCh38:
Chr11:121109432
TECTA, TBCEL-TECTAnot provided, Autosomal recessive nonsyndromic hearing loss 21, Autosomal dominant nonsyndromic hearing loss 12
Uncertain significance
(Jun 23, 2021)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr11:120980098
GRCh38:
Chr11:121109389
TBCEL-TECTA, TECTAT126IAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
27.
GRCh37:
Chr11:121039512
GRCh38:
Chr11:121168803
TBCEL-TECTA, TECTAnot provided, Autosomal recessive nonsyndromic hearing loss 21, Autosomal dominant nonsyndromic hearing loss 12
Conflicting interpretations of pathogenicity
(Feb 24, 2020)
criteria provided, conflicting interpretations
28.
GRCh37:
Chr11:121033067
GRCh38:
Chr11:121162358
TBCEL-TECTA, TECTAK1754EAutosomal recessive nonsyndromic hearing loss 21, Autosomal dominant nonsyndromic hearing loss 12Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
29.
GRCh37:
Chr11:121033012
GRCh38:
Chr11:121162303
TBCEL-TECTA, TECTAnot provided, Autosomal recessive nonsyndromic hearing loss 21, Autosomal dominant nonsyndromic hearing loss 12
Conflicting interpretations of pathogenicity
(Feb 11, 2022)
criteria provided, conflicting interpretations
30.
GRCh37:
Chr11:121028838
GRCh38:
Chr11:121158129
TBCEL-TECTA, TECTAD1532Nnot provided, Autosomal recessive nonsyndromic hearing loss 21, Autosomal dominant nonsyndromic hearing loss 12
Conflicting interpretations of pathogenicity
(Feb 5, 2022)
criteria provided, conflicting interpretations
31.
GRCh37:
Chr11:121032949
GRCh38:
Chr11:121162240
TBCEL-TECTA, TECTAnot provided, Autosomal recessive nonsyndromic hearing loss 21, Autosomal dominant nonsyndromic hearing loss 12
Conflicting interpretations of pathogenicity
(Dec 10, 2019)
criteria provided, conflicting interpretations
32.
GRCh37:
Chr11:121000868
GRCh38:
Chr11:121130159
LOC126861365, TBCEL-TECTA, TECTAAutosomal recessive nonsyndromic hearing loss 21, Autosomal dominant nonsyndromic hearing loss 12Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
33.
GRCh37:
Chr11:120999013
GRCh38:
Chr11:121128304
TBCEL-TECTA, TECTAQ776LAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
34.
GRCh37:
Chr11:120996305
GRCh38:
Chr11:121125596
TBCEL-TECTA, TECTAD500NAutosomal dominant nonsyndromic hearing loss 12, not provided, Autosomal recessive nonsyndromic hearing loss 21
Uncertain significance
(Aug 22, 2022)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr11:120989104
GRCh38:
Chr11:121118395
TBCEL-TECTA, TECTAC294Rnot provided, Autosomal recessive nonsyndromic hearing loss 21, Autosomal dominant nonsyndromic hearing loss 12
Uncertain significance
(May 12, 2022)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr11:120989074
GRCh38:
Chr11:121118365
TBCEL-TECTA, TECTAR284Cnot specified, Autosomal dominant nonsyndromic hearing loss 12, Inborn genetic diseases,
Autosomal recessive nonsyndromic hearing loss 21
Uncertain significance
(Feb 10, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr11:120989029
GRCh38:
Chr11:121118320
TBCEL-TECTA, TECTAR269GAutosomal recessive nonsyndromic hearing loss 21, Autosomal dominant nonsyndromic hearing loss 12Conflicting interpretations of pathogenicity
(Jan 12, 2018)
criteria provided, conflicting interpretations
38.
GRCh37:
Chr11:121032853
GRCh38:
Chr11:121162144
TBCEL-TECTA, TECTAAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21, not provided
Conflicting interpretations of pathogenicity
(Jul 4, 2023)
criteria provided, conflicting interpretations
39.
GRCh37:
Chr11:121023779
GRCh38:
Chr11:121153070
TBCEL-TECTA, TECTAK1432RAutosomal dominant nonsyndromic hearing loss 12, not provided, Autosomal recessive nonsyndromic hearing loss 21
Conflicting interpretations of pathogenicity
(May 5, 2021)
criteria provided, conflicting interpretations
40.
GRCh37:
Chr11:121016295
GRCh38:
Chr11:121145586
TBCEL-TECTA, TECTAK1192TAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
41.
GRCh37:
Chr11:120998908
GRCh38:
Chr11:121128199
TBCEL-TECTA, TECTAK741RAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
42.
GRCh37:
Chr11:120998861
GRCh38:
Chr11:121128152
TBCEL-TECTA, TECTAAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
43.
GRCh37:
Chr11:120984351
GRCh38:
Chr11:121113642
TBCEL-TECTA, TECTAAutosomal dominant nonsyndromic hearing loss 12, not provided, Autosomal recessive nonsyndromic hearing loss 21
Uncertain significance
(Feb 12, 2020)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr11:121058691
GRCh38:
Chr11:121187982
TBCEL-TECTA, TECTAAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
45.
GRCh37:
Chr11:121058610
GRCh38:
Chr11:121187901
TBCEL-TECTA, TECTAAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21Uncertain significance
(Mar 23, 2018)
criteria provided, single submitter
46.
GRCh37:
Chr11:121039513
GRCh38:
Chr11:121168804
TBCEL-TECTA, TECTAY1960HAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
47.
GRCh37:
Chr11:121037480
GRCh38:
Chr11:121166771
TBCEL-TECTA, TECTAAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
48.
GRCh37:
Chr11:121036071
GRCh38:
Chr11:121165362
TBCEL-TECTA, TECTAE1788KAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
49.
GRCh37:
Chr11:121031055
GRCh38:
Chr11:121160346
TBCEL-TECTA, TECTAV1634Anot provided, Autosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21
Uncertain significance
(Mar 8, 2019)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr11:121023652
GRCh38:
Chr11:121152943
TECTA, TBCEL-TECTAA1390TAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
51.
GRCh37:
Chr11:121000653
GRCh38:
Chr11:121129944
TBCEL-TECTA, TECTA, LOC126861365L892MAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21, Inborn genetic diseases,
not provided
Uncertain significance
(May 17, 2022)
criteria provided, multiple submitters, no conflicts
52.
GRCh37:
Chr11:120989367
GRCh38:
Chr11:121118658
TBCEL-TECTA, TECTAAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
53.
GRCh37:
Chr11:120989313
GRCh38:
Chr11:121118604
TBCEL-TECTA, TECTAAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
54.
GRCh37:
Chr11:120983846
GRCh38:
Chr11:121113137
TBCEL-TECTA, TECTAAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21, not specified,
not provided
Conflicting interpretations of pathogenicity
(May 26, 2021)
criteria provided, conflicting interpretations
55.
GRCh37:
Chr11:121023647
GRCh38:
Chr11:121152938
TBCEL-TECTA, TECTAR1388HAutosomal dominant nonsyndromic hearing loss 12, not provided, Autosomal recessive nonsyndromic hearing loss 21
Conflicting interpretations of pathogenicity
(Aug 28, 2021)
criteria provided, conflicting interpretations
56.
GRCh37:
Chr11:121037442
GRCh38:
Chr11:121166733
TBCEL-TECTA, TECTAS1847PAutosomal dominant nonsyndromic hearing loss 12Likely pathogenic
(Dec 28, 2017)
criteria provided, single submitter
57.
GRCh37:
Chr11:120998482
GRCh38:
Chr11:121127773
TBCEL-TECTA, TECTAS599TAutosomal dominant nonsyndromic hearing loss 12Uncertain significance
(Dec 28, 2017)
criteria provided, single submitter
58.
GRCh37:
Chr11:121028561
GRCh38:
Chr11:121157852
TBCEL-TECTA, TECTAnot provided, Autosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21
Conflicting interpretations of pathogenicity
(Jun 4, 2022)
criteria provided, conflicting interpretations
59.
GRCh37:
Chr11:120973403
GRCh38:
Chr11:121102694
TBCEL-TECTA, TECTAW10S, W329SAutosomal dominant nonsyndromic hearing loss 12Likely benigncriteria provided, single submitter
60.
GRCh37:
Chr11:121037391
GRCh38:
Chr11:121166682
TBCEL-TECTA, TECTAV1830M, V2144MAutosomal dominant nonsyndromic hearing loss 12, not providedConflicting interpretations of pathogenicity
(Aug 3, 2021)
criteria provided, conflicting interpretations
61.
GRCh37:
Chr11:120976565
GRCh38:
Chr11:121105856
TBCEL-TECTA, TECTAnot specified, Autosomal dominant nonsyndromic hearing loss 12, not provided,
Autosomal recessive nonsyndromic hearing loss 21
Conflicting interpretations of pathogenicity
(Mar 20, 2022)
criteria provided, conflicting interpretations
62.
GRCh37:
Chr11:121000679
GRCh38:
Chr11:121129970
LOC126861365, TBCEL-TECTA, TECTAAutosomal dominant nonsyndromic hearing loss 12, not specified, not provided,
Autosomal recessive nonsyndromic hearing loss 21
Conflicting interpretations of pathogenicity
(Sep 13, 2022)
criteria provided, conflicting interpretations
63.
GRCh37:
Chr11:120973407
GRCh38:
Chr11:121102698
TBCEL-TECTA, TECTAnot specified, not provided, Autosomal recessive nonsyndromic hearing loss 21,
Autosomal dominant nonsyndromic hearing loss 12
Conflicting interpretations of pathogenicity
(Feb 28, 2023)
criteria provided, conflicting interpretations
64.
GRCh37:
Chr11:121028646
GRCh38:
Chr11:121157937
TBCEL-TECTA, TECTAE1468*, E1787*Autosomal dominant nonsyndromic hearing loss 12Uncertain significance
(Nov 14, 2018)
criteria provided, single submitter
65.
GRCh37:
Chr11:120980179
GRCh38:
Chr11:121109470
TBCEL-TECTA, TECTAT153M, T472Mnot specified, not providedUncertain significance
(Jun 30, 2023)
criteria provided, multiple submitters, no conflicts
66.
GRCh37:
Chr11:120998774
GRCh38:
Chr11:121128065
TBCEL-TECTA, TECTAAutosomal dominant nonsyndromic hearing loss 12, not provided, Autosomal recessive nonsyndromic hearing loss 21
Conflicting interpretations of pathogenicity
(Aug 12, 2021)
criteria provided, conflicting interpretations
67.
GRCh37:
Chr11:121016805
GRCh38:
Chr11:121146096
TBCEL-TECTA, TECTAW1362*, W1681*Nonsyndromic genetic hearing lossPathogenic
(Jan 21, 2020)
reviewed by expert panel
FDA Recognized Database
68.
GRCh37:
Chr11:121058641
GRCh38:
Chr11:121187932
TBCEL-TECTA, TECTAD2034N, D2348NAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21, not provided
Uncertain significance
(Sep 17, 2021)
criteria provided, multiple submitters, no conflicts
69.
GRCh37:
Chr11:121016781
GRCh38:
Chr11:121146072
TBCEL-TECTA, TECTAT1354I, T1673IAutosomal recessive nonsyndromic hearing loss 21, Autosomal dominant nonsyndromic hearing loss 12, not provided
Conflicting interpretations of pathogenicity
(May 5, 2022)
criteria provided, conflicting interpretations
70.
GRCh37:
Chr11:121016574
GRCh38:
Chr11:121145865
TBCEL-TECTA, TECTAC1285S, C1604SAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21Uncertain significance
(Nov 13, 2015)
no assertion criteria provided
71.
GRCh37:
Chr11:121016463
GRCh38:
Chr11:121145754
TBCEL-TECTA, TECTAP1248L, P1567LAutosomal recessive nonsyndromic hearing loss 21, not specified, Hearing impairment,
not provided, Autosomal dominant nonsyndromic hearing loss 12
Conflicting interpretations of pathogenicity
(Feb 6, 2023)
criteria provided, conflicting interpretations
72.
GRCh37:
Chr11:121061505
GRCh38:
Chr11:121190796
TBCEL-TECTA, TECTAT2153M, T2467Mnot provided, Autosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21,
not specified
Conflicting interpretations of pathogenicity
(Mar 13, 2022)
criteria provided, conflicting interpretations
73.
GRCh37:
Chr11:121061475
GRCh38:
Chr11:121190766
TBCEL-TECTA, TECTAS2143L, S2457Lnot provided, Autosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21,
not specified
Conflicting interpretations of pathogenicity
(May 7, 2022)
criteria provided, conflicting interpretations
74.
GRCh37:
Chr11:121060523
GRCh38:
Chr11:121189814
TBCEL-TECTA, TECTAR2101W, R2415WAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
75.
GRCh37:
Chr11:121058677
GRCh38:
Chr11:121187968
TBCEL-TECTA, TECTAD2046N, D2360Nnot provided, Autosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21
Uncertain significance
(Dec 3, 2021)
criteria provided, multiple submitters, no conflicts
76.
GRCh37:
Chr11:121058676
GRCh38:
Chr11:121187967
TBCEL-TECTA, TECTAnot provided, Autosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21
Conflicting interpretations of pathogenicity
(Jun 7, 2021)
criteria provided, conflicting interpretations
77.
GRCh37:
Chr11:121039548
GRCh38:
Chr11:121168839
TBCEL-TECTA, TECTAAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
78.
GRCh37:
Chr11:121039543
GRCh38:
Chr11:121168834
TBCEL-TECTA, TECTAA1970T, A2284TAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21Conflicting interpretations of pathogenicity
(Jan 12, 2018)
criteria provided, conflicting interpretations
79.
GRCh37:
Chr11:121039464
GRCh38:
Chr11:121168755
TBCEL-TECTA, TECTAAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
80.
GRCh37:
Chr11:121039405
GRCh38:
Chr11:121168696
TBCEL-TECTA, TECTAP1924T, P2238TAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
81.
GRCh37:
Chr11:121038919
GRCh38:
Chr11:121168210
TBCEL-TECTA, TECTAM1915L, M2229Lnot provided, Autosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21
Uncertain significance
(Aug 25, 2022)
criteria provided, multiple submitters, no conflicts
82.
GRCh37:
Chr11:121038748
GRCh38:
Chr11:121168039
TBCEL-TECTA, TECTAAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
83.
GRCh37:
Chr11:121037501
GRCh38:
Chr11:121166792
TBCEL-TECTA, TECTAAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21, Autosomal dominant nonsyndromic hearing loss 12,
Autosomal recessive nonsyndromic hearing loss 21
Uncertain significance
(Jan 19, 2022)
criteria provided, multiple submitters, no conflicts
84.
GRCh37:
Chr11:121037486
GRCh38:
Chr11:121166777
TBCEL-TECTA, TECTAAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
85.
GRCh37:
Chr11:121037453
GRCh38:
Chr11:121166744
TBCEL-TECTA, TECTAI1850M, I2164MAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
86.
GRCh37:
Chr11:121037399
GRCh38:
Chr11:121166690
TBCEL-TECTA, TECTAI1832M, I2146MAutosomal dominant nonsyndromic hearing loss 12, Autosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21,
Autosomal recessive nonsyndromic hearing loss 21
Uncertain significance
(Jul 30, 2021)
criteria provided, multiple submitters, no conflicts
87.
GRCh37:
Chr11:121032921
GRCh38:
Chr11:121162212
TBCEL-TECTA, TECTAY1705C, Y2019CInborn genetic diseases, not provided, Autosomal dominant nonsyndromic hearing loss 12,
Autosomal recessive nonsyndromic hearing loss 21
Uncertain significance
(Dec 5, 2022)
criteria provided, multiple submitters, no conflicts
88.
GRCh37:
Chr11:121032898
GRCh38:
Chr11:121162189
TBCEL-TECTA, TECTAM1697I, M2011IInborn genetic diseases, not provided, Autosomal dominant nonsyndromic hearing loss 12,
Autosomal recessive nonsyndromic hearing loss 21
Uncertain significance
(Nov 10, 2022)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr11:121032772
GRCh38:
Chr11:121162063
TBCEL-TECTA, TECTAAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
90.
GRCh37:
Chr11:121031119
GRCh38:
Chr11:121160410
TBCEL-TECTA, TECTAAutosomal recessive nonsyndromic hearing loss 21, Autosomal dominant nonsyndromic hearing loss 12, Autosomal dominant nonsyndromic hearing loss 12,
Autosomal recessive nonsyndromic hearing loss 21
Uncertain significance
(Jul 15, 2021)
criteria provided, multiple submitters, no conflicts
91.
GRCh37:
Chr11:121030996
GRCh38:
Chr11:121160287
TBCEL-TECTA, TECTAAutosomal recessive nonsyndromic hearing loss 21, Autosomal dominant nonsyndromic hearing loss 12Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
92.
GRCh37:
Chr11:121030874
GRCh38:
Chr11:121160165
TBCEL-TECTA, TECTAI1574V, I1893VInborn genetic diseases, Autosomal dominant nonsyndromic hearing loss 12, not provided,
not specified, Autosomal recessive nonsyndromic hearing loss 21
Conflicting interpretations of pathogenicity
(Nov 1, 2022)
criteria provided, conflicting interpretations
93.
GRCh37:
Chr11:121028685
GRCh38:
Chr11:121157976
TBCEL-TECTA, TECTAS1481G, S1800GAutosomal dominant nonsyndromic hearing loss 12, not specified, not provided,
Autosomal recessive nonsyndromic hearing loss 21
Uncertain significance
(Sep 18, 2022)
criteria provided, multiple submitters, no conflicts
94.
GRCh37:
Chr11:121028581
GRCh38:
Chr11:121157872
TBCEL-TECTA, TECTAT1446R, T1765RAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
95.
GRCh37:
Chr11:121023773
GRCh38:
Chr11:121153064
TBCEL-TECTA, TECTAD1430G, D1749GAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
96.
GRCh37:
Chr11:121023689
GRCh38:
Chr11:121152980
TBCEL-TECTA, TECTAC1402S, C1721SMeniere disease, not provided, Autosomal recessive nonsyndromic hearing loss 21,
Autosomal dominant nonsyndromic hearing loss 12
Uncertain significance
(Oct 1, 2022)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr11:121016781
GRCh38:
Chr11:121146072
TBCEL-TECTA, TECTAT1354S, T1673SAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
98.
GRCh37:
Chr11:121016480
GRCh38:
Chr11:121145771
TBCEL-TECTA, TECTAM1254V, M1573VAutosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
99.
GRCh37:
Chr11:121016470
GRCh38:
Chr11:121145761
TBCEL-TECTA, TECTAAutosomal dominant nonsyndromic hearing loss 12, not specified, not provided,
Autosomal recessive nonsyndromic hearing loss 21
Conflicting interpretations of pathogenicity
(May 14, 2022)
criteria provided, conflicting interpretations
100.
GRCh37:
Chr11:121016448
GRCh38:
Chr11:121145739
TBCEL-TECTA, TECTAR1243H, R1562HAutosomal dominant nonsyndromic hearing loss 12, not provided, Autosomal recessive nonsyndromic hearing loss 21
Uncertain significance
(May 5, 2021)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination